Tampa Florida Hospital Revenue

Compiled from MSRB EMMA & public records · read-only public record · debt as of Sep 12, 2026 · latest trade Sep 11, 2026 · latest filing May 6, 2026

Bonds issued for Healthcare facilities

Credit ratings

agency-stated

Moody's

29 rated securities

S&P

A-

29 rated securities

Maturity profile

par maturing by year · as of Sep 2026

Recent activity

rating actions & filings

Quarterly / Monthly Financial Information filed

May 6, 2026 · Quarterly / Monthly Financial Information: 2026 3rd Quarter Una…

Quarterly / Monthly Financial Information filed

Feb 9, 2026 · Quarterly / Monthly Financial Information: 2026 2nd Quarter Cer…

Annual Financial Information and Operating Data filed

Nov 17, 2025 · Annual Financial Information and Operating Data: 2025 Operating…

Quarterly / Monthly Financial Information filed

Nov 6, 2025 · Quarterly / Monthly Financial Information: 2026 1st Quarter Una…

Audited Financial Statements or ACFR filed

Sep 26, 2025 · Audited Financial Statements or ACFR: 2025 Audited Financial St…

Quarterly / Monthly Financial Information filed

May 7, 2025 · Quarterly / Monthly Financial Information: 2025 3rd Quarter Una…

In context

Larger than 92% of FL issuers by debt outstanding · #156 of 1974

Debt overview

EMMA-derived

Outstanding par (EMMA est.)—

Securities30

Callable40%

Outstanding securities

Sort

Outstanding securities for Tampa Florida Hospital Revenue
CUSIP	Series / description	Coupon	Maturity	Outstanding	Ratings	First call
875161BZ3	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	5.0%	Jul 1, 2027	$2,335,000	Moody’s A2S&P A-	July 1, 2026
875161CN9	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2027	$1,415,000	Moody’s A2S&P A-	—
875161BH3	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	5.0%	Jul 1, 2027	$2,740,000	Moody’s A2S&P A-	—
875161CA7	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	5.0%	Jul 1, 2028	$2,455,000	Moody’s A2S&P A-	July 1, 2026
875161BJ9	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	3.75%	Jul 1, 2028	$2,880,000	Moody’s A2S&P A-	—
875161CP4	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2028	$1,440,000	Moody’s A2S&P A-	—
875161AS0	CAP IMPT-H LEE MOFFITT-SER A	5.75%	Jul 1, 2029	$21,610,000	—	—
875161BK6	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	3.75%	Jul 1, 2029	$2,990,000	Moody’s A2S&P A-	—
875161CQ2	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2029	$1,500,000	Moody’s A2S&P A-	—
875161CB5	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	5.0%	Jul 1, 2029	$2,580,000	Moody’s A2S&P A-	July 1, 2026
875161CR0	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2030	$2,385,000	Moody’s A2S&P A-	—
875161CC3	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	5.0%	Jul 1, 2030	$4,150,000	Moody’s A2S&P A-	July 1, 2026
875161BL4	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	4.0%	Jul 1, 2030	$195,000	Moody’s A2S&P A-	—
875161CF6	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	3.125%	Jul 1, 2030	$1,460,000	Moody’s A2S&P A-	July 1, 2026
875161CD1	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	3.25%	Jul 1, 2031	$5,855,000	Moody’s A2S&P A-	July 1, 2026
875161BM2	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	4.0%	Jul 1, 2031	$205,000	Moody’s A2S&P A-	—
875161CS8	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2031	$3,275,000	Moody’s A2S&P A-	July 1, 2030
875161CT6	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2032	$3,495,000	Moody’s A2S&P A-	July 1, 2030
875161BN0	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	4.0%	Jul 1, 2032	$215,000	Moody’s A2S&P A-	—
875161CU3	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2033	$3,195,000	Moody’s A2S&P A-	July 1, 2030
875161CV1	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2034	$3,370,000	Moody’s A2S&P A-	July 1, 2030
875161CW9	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2035	$3,550,000	Moody’s A2S&P A-	July 1, 2030
875161CX7	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2036	$3,745,000	Moody’s A2S&P A-	July 1, 2030
875161CY5	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	3.0%	Jul 1, 2037	$3,910,000	Moody’s A2S&P A-	July 1, 2030
875161CE9	TAMPA FLA HOSP REV REV REF BDS H LEE MOFFITT CANCER C…	5.0%	Jul 1, 2037	$45,065,000	Moody’s A2S&P A-	July 1, 2026
875161CZ2	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	4.0%	Jul 1, 2038	$13,020,000	Moody’s A2S&P A-	July 1, 2030
875161DA6	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	4.0%	Jul 1, 2039	$13,555,000	Moody’s A2S&P A-	July 1, 2030
875161DB4	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2040	$14,180,000	Moody’s A2S&P A-	July 1, 2030
875161DC2	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	4.0%	Jul 1, 2045	$80,455,000	Moody’s A2S&P A-	July 1, 2030
875161DD0	TAMPA FLA HOSP REV BDS H LEE MOFFITT CANCER CTR AND R…	5.0%	Jul 1, 2050	$100,860,000	Moody’s A2S&P A-	July 1, 2030

Market activity

EMMA · secondary trades · latest Sep 11, 2026

Each dot is a reported secondary trade — yield by trade date, sized by par, colored by trade side. Hover for detail.

Trade dateSecurityPriceYieldSizeSide

Sep 11 875161CE9 99.75 5.03% 25,000 Inter-Dealer Trade

Sep 11 875161CE9 99.85 5.02% 25,000 Customer Bought

Sep 11 875161CE9 99.75 5.03% 25,000 Inter-Dealer Trade

Sep 11 875161CE9 99.50 5.06% 25,000 Inter-Dealer Trade

Sep 10 875161DA6 88.51 5.24% 5,000 Inter-Dealer Trade

Sep 10 875161DA6 88.81 5.21% 5,000 Customer Bought

Sep 10 875161DA6 90.38 5.03% 100,000 Inter-Dealer Trade

Trade prints reported to the MSRB — a live market signal a manual issuer page cannot show.

19 callable securities carry a stated call price — refunding candidates as rates move.

Recent rating actions

Moody's · S&P · Fitch · KBRA

S&P Lee Moffitt Cancer Center & Research Institute, FL Outlook Revised To Positive On Revenue Growth, Positive Operations COLUMBIA (S&P…

Jul 12, 2021

Outlook A- Outlook Positive

View the filing on EMMA ↗

Rating actions as disclosed by the issuer to the MSRB’s EMMA system under SEC Rule 15c2-12; the ratings are the opinions of the respective rating agencies (Moody's, S&P Global Ratings, Fitch Ratings, KBRA). Dates are the rating-action dates stated in each notice.

Credit ratings

Maturity profile

Recent activity

Debt overview

Debt service

Outstanding securities

Market activity

Recent rating actions

Document library

Disclosure record

Standing

Credentials on record

Dated obligations

Record quality

Frequently asked questions